David‐Alexandre Gross

2.2k total citations
41 papers, 1.7k citations indexed

About

David‐Alexandre Gross is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, David‐Alexandre Gross has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 15 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in David‐Alexandre Gross's work include Immunotherapy and Immune Responses (20 papers), Virus-based gene therapy research (14 papers) and T-cell and B-cell Immunology (14 papers). David‐Alexandre Gross is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Virus-based gene therapy research (14 papers) and T-cell and B-cell Immunology (14 papers). David‐Alexandre Gross collaborates with scholars based in France, United States and Morocco. David‐Alexandre Gross's co-authors include Giuseppe Ronzitti, Federico Mingozzi, François A. Lemonnier, Kostas Kosmatopoulos, Jean Davoust, Stéphanie Graff‐Dubois, Pedro M. Sousa Alves, Salem Chouaı̈b, Olivier Faure and Olivier Danos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

David‐Alexandre Gross

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David‐Alexandre Gross France 23 911 898 529 458 143 41 1.7k
Nanette Mittereder United States 10 437 0.5× 905 1.0× 669 1.3× 323 0.7× 124 0.9× 11 1.6k
Thomas C. Harding United States 22 527 0.6× 1.3k 1.4× 585 1.1× 951 2.1× 138 1.0× 49 2.2k
Brian Tomkowicz United States 17 380 0.4× 988 1.1× 508 1.0× 345 0.8× 143 1.0× 22 1.8k
Michael Naso United States 14 313 0.3× 1.1k 1.2× 556 1.1× 290 0.6× 89 0.6× 28 1.8k
Shao‐An Xue United Kingdom 26 1.4k 1.5× 814 0.9× 652 1.2× 1.3k 2.7× 375 2.6× 46 2.6k
Gaby Brouns Netherlands 13 555 0.6× 851 0.9× 671 1.3× 346 0.8× 105 0.7× 17 1.5k
Lung-Ji Chang United States 23 517 0.6× 722 0.8× 360 0.7× 427 0.9× 100 0.7× 35 1.6k
Brad E. Hoffman United States 25 368 0.4× 965 1.1× 972 1.8× 552 1.2× 183 1.3× 35 2.0k
Melanie Galla Germany 26 506 0.6× 1.7k 1.9× 1.1k 2.1× 670 1.5× 114 0.8× 48 2.5k
Dina Markowitz United States 9 435 0.5× 1.3k 1.5× 1.0k 2.0× 447 1.0× 161 1.1× 12 2.0k

Countries citing papers authored by David‐Alexandre Gross

Since Specialization
Citations

This map shows the geographic impact of David‐Alexandre Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David‐Alexandre Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David‐Alexandre Gross more than expected).

Fields of papers citing papers by David‐Alexandre Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David‐Alexandre Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David‐Alexandre Gross. The network helps show where David‐Alexandre Gross may publish in the future.

Co-authorship network of co-authors of David‐Alexandre Gross

This figure shows the co-authorship network connecting the top 25 collaborators of David‐Alexandre Gross. A scholar is included among the top collaborators of David‐Alexandre Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David‐Alexandre Gross. David‐Alexandre Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vidal, Pierre, Benjamin Bertin, Evelyne Gicquel, et al.. (2023). Muscle‐specific, liver‐detargeted adeno‐associated virus gene therapy rescues Pompe phenotype in adult and neonate Gaa−/− mice. Journal of Inherited Metabolic Disease. 47(1). 119–134. 9 indexed citations
2.
Gross, David‐Alexandre, et al.. (2022). Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients. Frontiers in Immunology. 13. 857276–857276. 32 indexed citations
3.
Gross, David‐Alexandre, et al.. (2020). Of rAAV and Men: From Genetic Neuromuscular Disorder Efficacy and Toxicity Preclinical Studies to Clinical Trials and Back. Journal of Personalized Medicine. 10(4). 258–258. 17 indexed citations
4.
Ronzitti, Giuseppe, David‐Alexandre Gross, & Federico Mingozzi. (2020). Human Immune Responses to Adeno-Associated Virus (AAV) Vectors. Frontiers in Immunology. 11. 670–670. 241 indexed citations
5.
Chappert, Pascal, Dominique Urbain, Fanny Collaud, et al.. (2019). Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity. JCI Insight. 4(11). 17 indexed citations
6.
Gross, David‐Alexandre, Christian Leborgne, Pascal Chappert, et al.. (2019). Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide. Scientific Reports. 9(1). 3937–3937. 12 indexed citations
7.
Alonso, Ruby, Héloïse Flament, Sébastien Lemoine, et al.. (2018). Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node. Nature Communications. 9(1). 2113–2113. 70 indexed citations
8.
Gross, David‐Alexandre, Stéphanie Lorain, Fabiola Tros, et al.. (2017). Intradermal Immunization with rAAV1 Vector Induces Robust Memory CD8+ T Cell Responses Independently of Transgene Expression in DCs. Molecular Therapy. 25(10). 2309–2322. 6 indexed citations
9.
Goudin, Nicolas, Pascal Chappert, Jérôme Megret, et al.. (2016). Depletion of Regulatory T Cells Induces High Numbers of Dendritic Cells and Unmasks a Subset of Anti-Tumour CD8+CD11c+ PD-1lo Effector T Cells. PLoS ONE. 11(6). e0157822–e0157822. 13 indexed citations
10.
Lorain, Stéphanie, Pascal Chappert, Romain Hardet, et al.. (2014). Intrinsic Transgene Immunogenicity Gears CD8+ T-cell Priming After rAAV-Mediated Muscle Gene Transfer. Molecular Therapy. 23(4). 697–706. 17 indexed citations
11.
Boisgérault, Florence, et al.. (2013). Prolonged Gene Expression in Muscle Is Achieved Without Active Immune Tolerance Using MicrorRNA 142.3p-Regulated rAAV Gene Transfer. Human Gene Therapy. 24(4). 393–405. 45 indexed citations
12.
Sudres, Muriel, Virginie Vasseur, L. Brault, et al.. (2012). MyD88 Signaling in B Cells Regulates the Production of Th1-dependent Antibodies to AAV. Molecular Therapy. 20(8). 1571–1581. 48 indexed citations
13.
Mars, Lennart T., Jan Bauer, David‐Alexandre Gross, et al.. (2007). CD8 T Cell Responses to Myelin Oligodendrocyte Glycoprotein-Derived Peptides in Humanized HLA-A*0201-Transgenic Mice. The Journal of Immunology. 179(8). 5090–5098. 34 indexed citations
14.
Alves, Pedro M. Sousa, Olivier Faure, Stéphanie Graff‐Dubois, et al.. (2006). STEAP, a prostate tumor antigen, is a target of human CD8+ T cells. Cancer Immunology Immunotherapy. 55(12). 1515–1523. 57 indexed citations
15.
Charrier, Sabine, Daniel Stockholm, Paule Opolon, et al.. (2004). A lentiviral vector encoding the human Wiskott–Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Therapy. 12(7). 597–606. 98 indexed citations
16.
Nizard, Philippe, David‐Alexandre Gross, Alexandre Chenal, et al.. (2003). Anchoring cytokines to tumor cells for the preparation of anticancer vaccines without gene transfection in mice.. Journal of Immunotherapy. 26(1). 63–71. 14 indexed citations
17.
Scardino, Antonio, David‐Alexandre Gross, Pedro M. Sousa Alves, et al.. (2002). HER-2/ neu and hTERT Cryptic Epitopes as Novel Targets for Broad Spectrum Tumor Immunotherapy. The Journal of Immunology. 168(11). 5900–5906. 105 indexed citations
18.
Graff‐Dubois, Stéphanie, Olivier Faure, David‐Alexandre Gross, et al.. (2002). Generation of CTL Recognizing an HLA-A*0201-Restricted Epitope Shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 Tumor Antigens: Implication in a Broad-Spectrum Tumor Immunotherapy. The Journal of Immunology. 169(1). 575–580. 63 indexed citations
19.
Tourdot, Sophie, et al.. (2000). A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes. European Journal of Immunology. 30(12). 3411–3421. 115 indexed citations
20.
Sommer, F. Graham, et al.. (1982). Renal imaging with dual energy projection radiography. American Journal of Roentgenology. 138(2). 317–322. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nanette Mittereder Breakdown of academic impact, for papers by Thomas C. Harding Breakdown of academic impact, for papers by Brian Tomkowicz Breakdown of academic impact, for papers by Michael Naso Breakdown of academic impact, for papers by Shao‐An Xue Breakdown of academic impact, for papers by Gaby Brouns Breakdown of academic impact, for papers by Lung-Ji Chang Breakdown of academic impact, for papers by Brad E. Hoffman Breakdown of academic impact, for papers by Melanie Galla Breakdown of academic impact, for papers by Dina Markowitz
Rankless by CCL
2026